| Fariha Rub, MD | |
|
305 W Jackson St, Suite 200, Carbondale, IL 62901-1474 | |
| (618) 536-6621 | |
| (618) 453-1102 |
| Full Name | Fariha Rub |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 305 W Jackson St, Carbondale, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255747002 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 125065171 (Illinois) | Primary |
| 208M00000X | Hospitalist | 036141893 (Illinois) | Secondary |
| Entity Name | Advanced Inpatient Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669537692 PECOS PAC ID: 7719989276 Enrollment ID: O20070213000155 |
News Archive
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
The Obama administration approved new rules that beginning Jan. 1, 2015, extend minimum wage and overtime payment to nearly 2 million home healthcare workers. Many in the mostly female and minority workforce are paid more than federal minimum wage, now $7.25 an hour, but don't get time-and-a-half when they work more than 40 hours a week.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
› Verified 6 days ago
| Entity Name | Integritas Emergency Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790128817 PECOS PAC ID: 7113167446 Enrollment ID: O20130710000760 |
News Archive
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
The Obama administration approved new rules that beginning Jan. 1, 2015, extend minimum wage and overtime payment to nearly 2 million home healthcare workers. Many in the mostly female and minority workforce are paid more than federal minimum wage, now $7.25 an hour, but don't get time-and-a-half when they work more than 40 hours a week.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
› Verified 6 days ago
| Entity Name | Hospital Care Consultants Of Galesburg Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801242474 PECOS PAC ID: 1456643113 Enrollment ID: O20160718000343 |
News Archive
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
The Obama administration approved new rules that beginning Jan. 1, 2015, extend minimum wage and overtime payment to nearly 2 million home healthcare workers. Many in the mostly female and minority workforce are paid more than federal minimum wage, now $7.25 an hour, but don't get time-and-a-half when they work more than 40 hours a week.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fariha Rub, MD 305 W Jackson St, Suite 200, Carbondale, IL 62901-1474 Ph: (618) 536-6621 | Fariha Rub, MD 305 W Jackson St, Suite 200, Carbondale, IL 62901-1474 Ph: (618) 536-6621 |
News Archive
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.
Can a simple imaging test help predict the success of cancer treatment, even before the treatment is complete? To begin to answer this question, a new National Cancer Institute-funded clinical trial is using a novel PET imaging technique that could improve the early detection of tumor growth during treatment for esophageal and lung cancer.
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
The Obama administration approved new rules that beginning Jan. 1, 2015, extend minimum wage and overtime payment to nearly 2 million home healthcare workers. Many in the mostly female and minority workforce are paid more than federal minimum wage, now $7.25 an hour, but don't get time-and-a-half when they work more than 40 hours a week.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.
› Verified 6 days ago
Ashmeet Singh Sahni, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 300 W Oak St Ste 200, Carbondale, IL 62901 Phone: 618-536-6621 | |
Thomas Murphy, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W Jackson St Ste 200, Carbondale, IL 62901 Phone: 618-536-6621 | |
Sandhya Rani Grandhi, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2601 W Main St, Carbondale, IL 62901 Phone: 618-549-5361 Fax: 618-457-4542 | |
Brian Jay Reach, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W Oak St, Carbondale, IL 62901 Phone: 217-545-8000 | |
Jordyn Audrey Drake, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 300 W Oak St, Carbondale, IL 62901 Phone: 618-536-6621 | |
Scott K Schonewolf, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W Jackson St, Suite 200, Carbondale, IL 62901 Phone: 618-453-3777 Fax: 618-453-1102 | |
Artemus Holguin-mills, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 300 W Oak St, Carbondale, IL 62901 Phone: 618-536-6621 |